Pharmos(PARS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS)

PARS 2.700

+13.6%

Jan 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Omer Shvili who wrote (1204)	8/31/1998 9:02:00 AM
From: yosi s	of 1491

Omer I agree with your post. Since H. Aviv bought new shares recently. he could not have prior knowledge. The Knowledge is open, see their web site. ONLY 8 people died in the study. The rest is extrpolation. It is still possible that all those death may fall in the placebo. and placebo mortality is within range. Even 1 to 2 death in HU211 versus 6-7 in placebo is great news. (but no death in HU211 will make headlines.) It is pure speculation on my part. But if HU 211 has such an impact on mortality ,its is bound to improve over all fonction as well. But we got to wait for RESULTS. THIS IS BIG MEDICAL NEWS . Eventualy it will be big financial news. Yosi

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next